Adverum Biotechnologies, Inc. Increase (Decrease) in Receivables
Adverum Biotechnologies, Inc. reported Increase (Decrease) in Receivables of -$886.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2017-11-08
- Adverum Biotechnologies, Inc. increase (decrease) in receivables for the quarter ending 2017-09-30 was $0.00.
- Adverum Biotechnologies, Inc. increase (decrease) in receivables for the quarter ending 2017-06-30 was $0.00.
- Adverum Biotechnologies, Inc. increase (decrease) in receivables for the quarter ending 2017-03-31 was -$886.00K, a 232.63% decline year-over-year.
- Adverum Biotechnologies, Inc. increase (decrease) in receivables for the quarter ending 2016-09-30 was -$48.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | -$886.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$886.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$886.00K 10-Q · filed 2017-05-09 | ||
| 2016-09-30 | -$48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$136.00K derived: sum of 2 quarters · filed 2017-11-08 | $532.00K 10-Q · filed 2017-11-08 |
| 2016-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $580.00K 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $668.00K 10-Q · filed 2017-05-09 |